|
METAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.61891000000081E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.201500E-02 |
| Normal-vs-Stage2 |
7.814100E-02 |
| Normal-vs-Stage3 |
2.03399996845377E-09 |
| Normal-vs-Stage4 |
2.60200000434807E-08 |
| Stage1-vs-Stage2 |
5.212400E-01 |
| Stage1-vs-Stage3 |
3.58959999946507E-07 |
| Stage1-vs-Stage4 |
1.76257999999763E-05 |
| Stage2-vs-Stage3 |
7.510400E-02 |
| Stage2-vs-Stage4 |
8.034200E-02 |
| Stage3-vs-Stage4 |
9.627600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75088999999629E-05 |
| Normal-vs-AfricanAmerican |
1.565780E-04 |
| Normal-vs-Asian |
3.479600E-01 |
| Caucasian-vs-AfricanAmerican |
4.703000E-01 |
| Caucasian-vs-Asian |
3.971700E-02 |
| AfricanAmerican-vs-Asian |
1.522370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78739999999733E-05 |
| Normal-vs-Female |
5.194400E-04 |
| Male-vs-Female |
5.778600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.140090E-03 |
| Normal-vs-Age(41-60Yrs) |
4.006200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.29410000000185E-05 |
| Normal-vs-Age(81-100Yrs) |
6.801600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.918800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.503600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.161200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.319000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.884400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.039400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.827400E-01 |
| Normal-vs-Grade 2 |
4.165500E-02 |
| Normal-vs-Grade 3 |
3.01729999985234E-07 |
| Normal-vs-Grade 4 |
3.3547997713157E-10 |
| Grade 1-vs-Grade 2 |
4.262400E-01 |
| Grade 1-vs-Grade 3 |
3.406400E-02 |
| Grade 1-vs-Grade 4 |
1.521180E-03 |
| Grade 2-vs-Grade 3 |
5.62619999999736E-05 |
| Grade 2-vs-Grade 4 |
9.63399999776016E-08 |
| Grade 3-vs-Grade 4 |
8.176500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.430800E-01 |
| Normal-vs-ccB subtype |
1.73712999999021E-05 |
| ccA subtype-vs-ccB subtype |
7.76700000000297E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.9714000000064E-05 |
| Normal-vs-N1 |
1.978320E-03 |
| N0-vs-N1 |
2.913000E-01 |
|
|
